NanoForm Therapeutics Overview
- Founded
-
2010
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
NanoForm Therapeutics General Information
Description
Developer of nano-active pharmaceutical therapies designed to treat serious diseases. The company is developing a proprietary technology called NanoActive, which delivers improvements in compound solubility, permeability and pharmaco-kinetics that can be applied across a diverse array of chemical and biological compounds.
Contact Information
Website
www.nanoformtherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Devonshire House
- 60 Goswell Road
- London EC1M 7AD
- England, United Kingdom
NanoForm Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Jul-2019 | 00.000 | Completed | Out of Business | ||
| 1. Early Stage VC | 31-Dec-2010 | 00.000 | 00.000 | Completed | Startup |
NanoForm Therapeutics Patents
NanoForm Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011266808-A1 | Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them | Active | 18-Jun-2010 | 00000000 | |
| AU-2011266808-B2 | Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them | Inactive | 18-Jun-2010 | 00000000 | |
| EP-2582697-A1 | Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them | Active | 18-Jun-2010 | 00000000 | |
| EP-2582697-B1 | Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them | Inactive | 18-Jun-2010 | 00000000 | 0 |
| ES-2655614-T3 | Nanostructured compositions of aprepitant, procedure for their preparation and pharmaceutical compositions containing them | Active | 18-Jun-2010 | A61K9/14 |